Related Experiment Videos

Osteoporosis: pathogenesis and clinical intervention

G Mueller1, R G G Russell

  • 1The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedic Surgery, Nuffield Orthopaedic Centre, Headington, Oxford OX3 7LD, U.K.

Biochemical Society Transactions
|March 26, 2003
PubMed

Insights

Osteoporosis is a common aging-related bone disorder. Recent advances offer drug treatments to prevent bone loss and fractures, with future prospects for targeting underlying pathogenic processes.

Area of Science:

  • Gerontology
  • Orthopedics
  • Pathology

Background:

  • Musculoskeletal tissues undergo age-related changes, contributing to common skeletal disorders in the elderly.
  • Bone tissue changes lead to osteoporosis and fractures.
  • Muscle (sarcopenia) and cartilage changes contribute to frailty and osteoarthritis, respectively.

Purpose of the Study:

  • To summarize recent advancements in understanding osteoporosis pathogenesis.
  • To review current drug treatments for osteoporosis.
  • To discuss future prospects in modifying osteoporosis-related pathogenic processes.

Main Methods:

  • Literature review of recent research on osteoporosis.
  • Analysis of pathogenic mechanisms contributing to bone loss and fragility.
  • Evaluation of current and emerging therapeutic strategies.

Main Results:

  • Significant progress has been made in understanding the pathogenic processes of osteoporosis.
  • Effective drug treatments are available to prevent bone loss and reduce fracture risk.
  • Future therapeutic strategies may target specific pathogenic pathways.

Conclusions:

  • Osteoporosis is a multifactorial condition influenced by aging.
  • Current treatments can effectively manage bone loss and fracture risk.
  • Ongoing research holds promise for novel therapeutic interventions targeting disease mechanisms.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...